Search clinical trials for: programmed cell death 1 (PD-1) inhibitor
Total 137790 results
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingGastric Cancer | Esophagogastric Junction Adenocarcinoma
-
Diwakar DavarAculeus TherapeuticsCompletedNSCLC | Metastatic Colorectal Carcinoma | Refractory MelanomaUnited States
-
The First Affiliated Hospital with Nanjing Medical...Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingEsophageal Squamous Cell CarcinomaChina
-
Shanghai Zhongshan HospitalRecruiting
-
Ningbo No. 1 HospitalRecruitingPrimary Central Nervous System LymphomaChina
-
Ningbo No. 1 HospitalRecruitingCardiovascular Diseases | Mental DisorderChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, Renal CellUnited States, Colombia, Canada, Australia, Finland, Japan, United Kingdom, Brazil, Chile, China, Croatia, Czechia, Denmark, France, Germany, Guatemala, Hungary, Ireland, Italy, Korea, Republic of, Malaysia, Mexico, Norway, Philippines, Polan... and more
-
Sun Yat-sen UniversityInnovent Biologics (Suzhou) Co. Ltd.RecruitingPancreatic Adenocarcinoma MetastaticChina
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Peripheral T-cell LymphomaChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital of Jinan University; Shenzhen University General...RecruitingCarcinoma | Digestive System Neoplasms | Intrahepatic Cholangiocarcinoma | First-line Treatment | PD-1 InhibitorChina
-
Jason J. Luke, MDRecruitingMelanoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumors | Cholangiocarcinoma | Bladder Cancer | Renal Cancer | Anal Cancer | Merkel Cell Carcinoma | HNSCCUnited States
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Changhai HospitalNot yet recruitingHER-2 Protein Overexpression | Esophageal Squamous Carcinoma
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, France, Belgium, Israel, Spain, United Kingdom, Korea, Republic of, Taiwan, Australia, Netherlands, Japan, Germany, Ukraine, Canada, Ireland, Italy, Poland, Russian Federation
-
Eisai Inc.Merck Sharp & Dohme LLCActive, not recruitingEndometrial NeoplasmsFrance, Canada, United States, Spain, United Kingdom, Italy, Taiwan, Korea, Republic of, Colombia, Australia, New Zealand, Brazil, Turkey, Poland, Israel, Argentina, Germany, Ireland, Japan, Mexico, Russian Federation
-
RenJi HospitalRecruitingUpper Urinary Tract Urothelial Carcinoma | Kidney Preservation | HER-2 ADC | PD-1antibodyChina
-
Oslo University HospitalTerminatedNon-small Cell Lung CancerNorway
-
Shanghai First Maternity and Infant HospitalUnknownProgrammed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer (ECCT)Endometrial Cancer Stage I
-
Merck Sharp & Dohme LLCCompleted
-
The N.1 Institute for Health (N.1)AccesetCompleted
-
Agenus Inc.CompletedCervical Cancer | Advanced CancerFrance, United States, Belgium, Australia, Spain, Estonia, Brazil, Chile, Poland
-
Women's Hospital School Of Medicine Zhejiang UniversityAkesoNot yet recruitingCervical Cancer | Uterine Cervical Neoplasms | Cancer of Cervix | Uterine Cervical Cancer | Cervical Neoplasms | Cancer of the Uterine Cervix
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedBreast Cancer | Neoplasm MetastasisJapan
-
Taiho Pharmaceutical Co., Ltd.CompletedChemotherapy-Induced Nausea and VomitingJapan
-
Lei LiRecruitingCervical Carcinoma | Immunotherapy | Survival Outcomes | Adverse Events | Locally Advanced Cervical Cancer | Chemoradiotherapy | Immune Checkpoint Inhibitor | Anti-programmed Cell Death Receptor 1 | Early Stage Cervical CancerChina
-
RenJi HospitalBeiGene; Huidu Shanghai Medical Sciences LtdRecruitingUrologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Antineoplastic Agents | Tislelizumab Antineoplastic Agents, ImmunologicalChina
-
Memorial Sloan Kettering Cancer CenterXencor, Inc.Active, not recruiting
-
Incyte CorporationCompletedHepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Triple Negative Breast Cancer | Pancreatic Ductal Adenocarcinoma | Castration Resistant Prostate Cancer | Gastric/ Gastroesophageal Junction | Squamous Carcinoma...United States, Spain, France, United Kingdom, Italy, Belgium
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
Di WuNot yet recruitingUndifferentiated Pleomorphic Sarcoma | Soft Tissue SarcomasChina
-
Beijing Tongren HospitalRecruitingT-lymphoblastic Lymphoma | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Fudan UniversityNot yet recruitingthe Efficacy and Safety of PD-1 Inhibitors With or Without Radiotherapy in Patients With Advanced MelanomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Tohoku UniversityCompleted
-
Fudan UniversityShanxi Province Cancer Hospital; Inner Mongolia Cancer Hospital Affiliated...RecruitingAdvanced Thyroid Cancer Patients Who Received Target TherapyChina
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.CompletedCholangiocarcinoma | Biliary Tract CancerChina
-
Curis, Inc.CompletedAdvanced Solid Tumors or LymphomasUnited States, Spain, Korea, Republic of, United Kingdom
-
Hunan Cancer HospitalXiangya Hospital of Central South University; Innovent Biologics (Suzhou) Co...UnknownSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer RecurrentChina
-
Shandong Provincial HospitalUnknownRelapsed/Refractory Non-Hodgkin's LymphomaChina
-
Lu HuaNot yet recruitingBreast Cancer Patients With Chronic Pain After SurgeryChina
-
Cukurova UniversityNot yet recruitingPatient Acceptance of Health Care | Drug Compliance
-
Peking Union Medical College HospitalRecruitingHepatocellular Carcinoma | PD-1 Inhibitor | RegorafenibChina
-
The Second Hospital of Hebei Medical UniversityRecruiting
-
Symphogen A/SActive, not recruitingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSolid Tumor | Metastatic CancerUnited States, Canada
-
Oxford Brookes UniversityUniversity of OxfordCompletedPhysical Activity | Mental Health Wellness 1 | Cognitive Function 1, Social | Academic Attainment | Fitness TestingUnited Kingdom
-
Diwakar DavarMerck Sharp & Dohme LLC; Gateway for Cancer ResearchNot yet recruitingPD-1 Refractory Advanced MelanomaUnited States
-
Fujian Cancer HospitalNot yet recruitingLung Adenocarcinoma | PD-1 Inhibitor | Stage IV Non-small Cell Lung Cancer | VEGF
-
Sichuan UniversityRecruitingNSCLC | PD-1 Inhibitor | Stereotactic Body Radiotherapy | Low Dose RadiotherapyChina
-
Asha NayakMerck Sharp & Dohme LLC; Oncovir, Inc.Completed